| abstract |
The present invention provides a compound of formula (I), a pharmaceutical composition thereof, a process for the preparation of said compound, and a use of said compound as a therapeutic agent, which can modulate the activity of histone lysine demethylating enzyme (KDM). The compounds of formula I act as KDM inhibitors with significant efficacy and have the potential for pharmaceutical intervention of any other disease associated with cancer and KDM control disorders. ≪ Structural Formula (I) > |